Deauville Score: A 5-point visual scale for interpreting FDG-PET/CT scans in lymphoma. Uses the mediastinum and liver as internal standards for uptake and comparison.
Guidelines & Evidence
Clinical Details
Section 1
When to Use
When to Use
Interim and end-of-treatment assessment of FDG-PET/CT scans in Hodgkin Lymphoma (HL) and certain Non-Hodgkin Lymphomas (NHL).
Determining treatment response (Complete Response vs. Partial Response).
Decision support for response-adapted therapy (e.g., escalating/de-escalating chemotherapy).
Patient Population
Primarily used in patients with FDG-avid lymphomas, specifically Hodgkin Lymphoma and Diffuse Large B-cell Lymphoma (DLBCL).
When Not to Rely on This Score Alone
Non-avid lymphomas (e.g., CLL/SLL, Marginal Zone Lymphoma) — PET uptake may be naturally low and unreliable.
Inflammatory conditions — Sarcoidosis, infection, or recent surgery can cause false-positive uptake (mimicking Grade 4/5).
Primary CNS Lymphoma — uptake characteristics differ from systemic lymphoma.
Section 2
Formula & Logic
Grading scale
Score
Definition
Interpretation
1
No uptake above background
Negative
2
Uptake ≤ mediastinum (blood pool)
Negative
3
Uptake > mediastinum BUT ≤ liver
Negative (in most settings)
4
Uptake moderately > liver
Positive
5
Uptake markedly > liver and/or new lesions
Positive
X
New areas of uptake unlikely to be lymphoma
Unclear
Section 3
Pearls/Pitfalls
The Liver Reference
The liver is the most critical reference point. In interim PET scans, a Score 1-3 is generally considered a complete metabolic response (CMR). A score 4-5 indicates residual disease.
Clinical Consequences
In some protocols (e.g., R-CHOP for DLBCL), a Deauville 3 at the end of treatment is still considered a "negative" result, whereas in others, it might warrant closer monitoring.
Section 4
Evidence Appraisal
Primary Scale
Report on the First International Workshop on Interim-PET-Scan in Lymphoma.
Meignan M et al. • Leukemia & Lymphoma. 2009;50(8):1257-1260.
The score was developed during a workshop in Deauville, France, to replace the qualitative "positive/negative" reporting with a more objective 5-point visual scale using internal reference organs (mediastinum and liver).